Patents Assigned to Nulixir Inc.
-
Patent number: 12485091Abstract: Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.Type: GrantFiled: June 30, 2022Date of Patent: December 2, 2025Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 12350367Abstract: Provided is a multilayer particle, the particle including: a core including: a first active ingredient; and a first polymer; a first shell, substantially surrounding the core, the first shell including: a second polymer; a second shell, substantially surrounding the first shell, the second shell including: a third polymer; and a plurality of emulsifying agents.Type: GrantFiled: September 14, 2020Date of Patent: July 8, 2025Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 11964049Abstract: Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.Type: GrantFiled: March 18, 2022Date of Patent: April 23, 2024Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 11793753Abstract: Provided is a method of encapsulation, the method including: providing a first mixture, the first mixture including: a first carrier; and a first active ingredient; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture, the second mixture including: a second carrier; and a first emulsifying agent; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture, wherein: the mixing is performed at a third temperature; and the third temperature is lower than the first temperature; and cooling the third mixture until the third mixture reaches a fourth temperature, wherein: the second carrier is in solid state at the fourth temperature.Type: GrantFiled: September 14, 2020Date of Patent: October 24, 2023Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 11446245Abstract: Provided is a composition including a first phase comprising a first filler; a second phase, the second phase comprising a second filler; and a third phase comprising a third filler; and a fourth phase comprising a fourth filler; and a first active ingredient, wherein the first active ingredient is selected from the group consisting of caffeine, Echinacea purpurea, Echinacea angustifolia, Echinacea pallida, Acmella oleracea, Helichrysum umbraculigerum, Radula marginata, kava, kanna, black truffle, Syzygium aromaticum, Rosmarinus oficinalis, basil, oregano, lavender, true cinnamon, malabathrum, cananga odorata, Riboflavin, theanine, Ginkgo Biloba, Bacopa, Rhodiola Rosea, and combinations thereof.Type: GrantFiled: January 29, 2021Date of Patent: September 20, 2022Assignee: NULIXIR INC.Inventor: Ehsan Moaseri
-
Patent number: 11351117Abstract: Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.Type: GrantFiled: September 14, 2020Date of Patent: June 7, 2022Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 11318094Abstract: Provided is a composition for oral administration, the composition including: a dispersion medium including: an aqueous solution; and a dispersed phase including: a population of particles, each particle including: a core including: a first active ingredient; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a lipophilic carrier; and a plurality of emulsifying agents; wherein the particle retards the release of the first active ingredient after consumption.Type: GrantFiled: September 14, 2020Date of Patent: May 3, 2022Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 11123291Abstract: Provided is a method of encapsulation, the method including: providing a first mixture; applying heat to the first mixture until the first mixture reaches a first temperature; providing a second mixture; applying heat to the second mixture until the second mixture reaches a second temperature; mixing the first mixture with the second mixture to obtain a third mixture; providing a fourth mixture; applying heat to the fourth mixture until the fourth mixture reaches a third temperature; mixing the third mixture with the fourth mixture to obtain a fifth mixture.Type: GrantFiled: September 14, 2020Date of Patent: September 21, 2021Assignee: Nulixir Inc.Inventor: Ehsan Moaseri
-
Patent number: 10945953Abstract: Provided is a composition including a dispersion medium including: an aqueous solution; a first active ingredient; a flavor agent; and a first type of polymer; and a dispersed phase including: a population of particles, each particle including: a core including: a second active ingredient a second type of polymer; and an aqueous solution; a shell, substantially surrounding the core, the shell including: a third type of polymer; a plurality of lipophilic carriers; and a third active ingredient; and a plurality of emulsifying agents.Type: GrantFiled: September 14, 2020Date of Patent: March 16, 2021Assignee: Nulixir Inc.Inventor: Ehsan Moaseri